Appointments in pharmaceutical in Quebec, September 2022
Sébastien Martel @Pfizer
Sébastien Martel received a promotion and has been appointed Global Marketing Director, Prevenar Pediatric at Pfizer where he had formerly been a National Business Director - Vaccines.
Tara Brohman @Pfizer
Tara Brohman was hired by Pfizer as a Commercial Manager Breast Cancer in Montreal. Until recently, she was working as a Brand Manager, Hematology-Oncology, Acute Myeloid Leukemia (AML).
Talia Rochman @MEDISCA
Talia Rochman has taken up the role of Senior Manager, Training and Organizational Development at MEDISCA in Montreal. She had been a Manager, Training & Education at Medicom Group previously.
Mary Bazo @AbbVie
Mary Bazo was hired by AbbVie as a QA Specialist, compliance and documentation in Montreal. She was previously employed as a QA Operations Specialist at Groupe PARIMA Inc.
Mahrukh Imran @Seqirus
Mahrukh Imran has become Manager, Center for Outcomes Research & Epidemiology (CORE), Medical Affairs at Seqirus in Montreal where she was working as a Real-World Evidence Analyst, Medical Affairs.
Marc Lapointe @Jubilant Radiopharma
Marc Lapointe has been appointed as an Associate General Counsel & Privacy Officer at Jubilant Radiopharma in Montreal. Before that he worked as Senior Legal Counsel at Jubilant DraxImage.
Isabelle-Claude Poulin @A&C Your Global GMP Partner - by Aceto
After working at MilliporeSigma, Isabelle-Claude Poulin has gotten the job of Associate Director Business Development Canada at A&C Your Global GMP Partner - by Aceto in Laval.
Bernard Lévesque @Pharmascience
Bernard Lévesque will now occupy the functions of Information Technology Portfolio Manager at Pharmascience where he had been an IT Project Lead.
Hanchata Martin @Pfizer
Hanchata Martin formerly Biosimilar Commercial Lead and Commercial Development at Pfizer has been appointed Director, Global pipeline commercial development-Pfizer Hospital.
Adam Yuck @Merck
Adam Yuck has become Director, Business Unit Head, Infectious Disease & Specialty Medicines at Merck where he had worked before as a Director, Business Unit Head, Virology (COVID-19, HIV).